Figure 8From: Brachytherapy boost in loco-regionally advanced nasopharyngeal carcinoma: a prospective randomized trial of the International Atomic Energy AgencyOverall survival by age. There is an advantage in overall survival for patients younger than 40 years (p = 0.014).Back to article page